Kristina Weber
Carl Neuberg Str. 1
Hannover, NI 30625, Germany
Hannover, NI 30625, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Quality-of-life scores improve after 96 weeks of PEG-IFNa-2a treatment of hepatitis D: An analysis of the HIDIT-II trial.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: December 16, 2022
Long-term safety of satralizumab in neuromyelitis optica spectrum disorder (NMOSD) from SAkuraSky and SAkuraStar.
Journal: Multiple sclerosis and related disorders
Published: April 14, 2022
Cardiogenic shock following yew needle poisoning : Digoxin immune fab, va-ECMO and albumin dialysis for the treatment of a suicidal yew leaf poisoning
Journal: Der Anaesthesist
Published: April 12, 2021
Resuscitation of children during the SARS-CoV-2 pandemic-a balance between self-protection and the factor of time
Journal: Notfall & rettungsmedizin
Published: August 31, 2020
Digoxin-mortality: randomized vs. observational comparison in the DIG trial.
Journal: European heart journal
Published: December 07, 2018
Rationale and design of the DIGIT-HF trial (DIGitoxin to Improve ouTcomes in patients with advanced chronic Heart Failure): a randomized, double-blind, placebo-controlled study.
Journal: European journal of heart failure
Published: November 19, 2018
Comparison of relative and absolute rectal dose-volume parameters and clinical correlation with acute and late radiation proctitis in prostate cancer patients.
Journal: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
Published: May 08, 2018
Commentary: On the levels of patient selection in registry-based randomized controlled trials.
Journal: Trials
Published: April 30, 2018
Peginterferon alfa-2a plus tenofovir disoproxil fumarate for hepatitis D (HIDIT-II): a randomised, placebo controlled, phase 2 trial.
Journal: The Lancet. Infectious diseases
Published: April 26, 2018
New research strategy with ambiguous implications: A comment on "Planning future studies based on the conditional power of a meta-analysis".
Journal: Statistics in medicine
Published: April 05, 2017
A plea to provide best evidence in trials under sample-size restrictions: the example of pioglitazone to resolve leukoplakia and erythroplakia in Fanconi anemia patients.
Journal: Orphanet journal of rare diseases
Published: March 06, 2017
How to use prior knowledge and still give new data a chance?
Journal: Pharmaceutical statistics
Published: December 21, 2016
Last Updated: 09/26/2026